Decoy Therapeutics Inc. Capital Expenditures
Decoy Therapeutics Inc. (DCOY) reported Capital Expenditures of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2022-03-25
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $2.60K.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $0.00.
- Decoy Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Payments to Acquire Property, Plant, and Equipment 1 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 4 month | Payments to Acquire Property, Plant, and Equipment 4 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 10 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-25 | |||||||
| 2020-12-31 | $2.60K 10-K · filed 2022-03-25 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-18 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | $15.40K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | $15.40K derived: sum of 3 quarters · filed 2019-03-06 | $59.76K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 | $15.40K derived: sum of 2 quarters · filed 2019-03-06 | $59.76K derived: sum of 3 quarters · filed 2019-03-06 | $91.35K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-12-31 | $15.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $59.76K derived: sum of 2 quarters · filed 2019-03-06 | $91.35K derived: sum of 3 quarters · filed 2019-03-06 | $113.50K 10-K · filed 2019-03-06 | ||||
| 2017-09-30 | $44.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $75.95K derived: sum of 2 quarters · filed 2018-11-05 | $98.10K 10-Q · filed 2018-11-05 | $148.49K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-06-30 | $31.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $53.74K 10-Q · filed 2018-08-01 | $104.13K derived: sum of 3 quarters · filed 2019-03-06 | $322.92K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-03-31 | $22.15K 10-Q · filed 2018-05-02 | $72.54K derived: sum of 2 quarters · filed 2019-03-06 | $291.33K derived: sum of 3 quarters · filed 2019-03-06 | $474.24K derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2016-12-31 | $50.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $269.18K derived: sum of 2 quarters · filed 2019-03-06 | $452.09K derived: sum of 3 quarters · filed 2019-03-06 | $559.38K 10-K · filed 2019-03-06 | ||||
| 2016-09-30 | $218.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $401.70K derived: sum of 2 quarters · filed 2017-11-06 | $508.99K 10-Q · filed 2017-11-06 | $551.34K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $182.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $290.20K 10-Q · filed 2017-08-02 | $332.55K derived: sum of 3 quarters · filed 2018-03-07 | $480.26K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $107.29K 10-Q · filed 2017-05-03 | $149.64K derived: sum of 2 quarters · filed 2018-03-07 | $297.34K derived: sum of 3 quarters · filed 2018-03-07 | $346.51K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | $42.35K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $190.06K derived: sum of 2 quarters · filed 2018-03-07 | $239.22K derived: sum of 3 quarters · filed 2018-03-07 | $265.62K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $147.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $196.87K derived: sum of 2 quarters · filed 2016-11-02 | $223.26K 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | $49.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $75.56K 10-Q · filed 2016-08-03 | ||||||
| 2015-03-31 | $26.39K 10-Q · filed 2016-05-04 | |||||||
| 2014-12-31 | $76.14K 10-K · filed 2017-03-08 | |||||||
| 2014-06-30 | $59.10K 10-Q · filed 2015-11-04 | $34.41K 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |